Literature DB >> 1998337

Characterization of a large deletion associated with a polymorphic block of repeated dinucleotides in the type III procollagen gene (COL3A1) of a patient with Ehlers-Danlos syndrome type IV.

B Lee1, M D'Alessio, H Vissing, F Ramirez, B Steinmann, A Superti-Furga.   

Abstract

Ehlers-Danlos syndrome type IV (EDS IV) is an autosomal dominant condition characterized by extreme fragility of skin, blood vessels, intestine, gravid uterus, and lungs. The phenotype is accounted for by mutations affecting the integrity and/or synthesis of the precursor procollagen molecules of type III collagen. In this article, we report the elucidation of the molecular defect in an EDS IV patient whose type III collagen was previously found to be structurally abnormal. We utilized PCR in a two-step process involving first the localization of the mutation in the mRNA and then the characterization of the defect in the gene. The results established the patient's heterozygosity for a genomic deletion of about 7.5 kb which eliminates 1,026 nucleotides of coding sequences in the message. The mutation arose as a result of an exon-to-intron recombination. The deleted segment extends from the 13th nucleotide of exon 9 to within a DNA sequence of intron 24, which is composed of a series of dinucleotide repeats. Using PCR, we tested the polymorphic nature of this DNA element on several unrelated individuals. Analysis of amplified genomic products of 45 chromosomes recognized at least four distinct allelic forms that display frequencies ranging from 5% to 61%. Mendelian segregation of three of the four alleles was established by the same method in a 3-generation family.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1998337      PMCID: PMC1682995     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  Isolation of cDNA and genomic clones encoding human pro-alpha 1 (III) collagen. Partial characterization of the 3' end region of the gene.

Authors:  M L Chu; D Weil; W de Wet; M Bernard; M Sippola; F Ramirez
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

2.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

3.  Detection of restriction fragment length polymorphisms at the centromeres of human chromosomes by using chromosome-specific alpha satellite DNA probes: implications for development of centromere-based genetic linkage maps.

Authors:  H F Willard; J S Waye; M H Skolnick; C E Schwartz; V E Powers; S B England
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Impaired secretion of type III procollagen in Ehlers-Danlos syndrome type IV fibroblasts: correction of the defect by incubation at reduced temperature and demonstration of subtle alterations in the triple-helical region of the molecule.

Authors:  A Superti-Furga; B Steinmann
Journal:  Biochem Biophys Res Commun       Date:  1988-01-15       Impact factor: 3.575

5.  Hypervariable 'minisatellite' regions in human DNA.

Authors:  A J Jeffreys; V Wilson; S L Thein
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

6.  Ehlers-Danlos syndrome type IV: a multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen.

Authors:  A Superti-Furga; E Gugler; R Gitzelmann; B Steinmann
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

7.  Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts.

Authors:  P H Byers; K A Holbrook; G S Barsh; L T Smith; P Bornstein
Journal:  Lab Invest       Date:  1981-04       Impact factor: 5.662

8.  Synthesis of an altered type III procollagen in a patient with type IV Ehlers-Danlos syndrome. A structural change in the alpha 1(III) chain which makes the protein more susceptible to proteinases.

Authors:  C A Stolle; R E Pyeritz; J C Myers; D J Prockop
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

9.  Further evidence for the dispersion of the human fibrillar collagen genes.

Authors:  C Huerre-Jeanpierre; M G Mattei; D Weil; K H Grzeschik; M L Chu; F O Sangiorgi; M E Sobel; F Ramirez; C Junien
Journal:  Am J Hum Genet       Date:  1986-01       Impact factor: 11.025

10.  Human alpha 1(III) and alpha 2(V) procollagen genes are located on the long arm of chromosome 2.

Authors:  B S Emanuel; L A Cannizzaro; J M Seyer; J C Myers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

View more
  13 in total

1.  A 27-bp deletion from one allele of the type III collagen gene (COL3A1) in a large family with Ehlers-Danlos syndrome type IV.

Authors:  A J Richards; J C Lloyd; P Narcisi; P N Ward; A C Nicholls; A De Paepe; F M Pope
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

2.  Substitution of aspartate for glycine 1018 in the type III procollagen (COL3A1) gene causes type IV Ehlers-Danlos syndrome: the mutated allele is present in most blood leukocytes of the asymptomatic and mosaic mother.

Authors:  S Kontusaari; G Tromp; H Kuivaniemi; C Stolle; F M Pope; D J Prockop
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

Review 3.  Genetic causes of aortic aneurysms. Unlearning at least part of what the textbooks say.

Authors:  H Kuivaniemi; G Tromp; D J Prockop
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

Review 4.  Ehlers-Danlos syndrome has varied molecular mechanisms.

Authors:  F M Pope; N P Burrows
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

5.  Are some apparently simple deletions actually two concerted deletions that result from interacting RY(i) hairpin loops?

Authors:  R P Ketterling; D Liao; S S Sommer
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

Review 6.  Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.

Authors:  Helena Kuivaniemi; Gerard Tromp
Journal:  Gene       Date:  2019-05-07       Impact factor: 3.688

7.  A T+6 to C+6 mutation in the donor splice site of COL3A1 IVS7 causes exon skipping and results in Ehlers-Danlos syndrome type IV.

Authors:  J Lloyd; P Narcisi; A Richards; F M Pope
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

8.  A single base mutation in the gene for type III collagen (COL3A1) converts glycine 847 to glutamic acid in a family with Ehlers-Danlos syndrome type IV. An unaffected family member is mosaic for the mutation.

Authors:  A J Richards; P N Ward; P Narcisi; A C Nicholls; J C Lloyd; F M Pope
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

9.  Characterization of a type II collagen gene (COL2A1) mutation identified in cultured chondrocytes from human hypochondrogenesis.

Authors:  W A Horton; M A Machado; J Ellard; D Campbell; J Bartley; F Ramirez; E Vitale; B Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

10.  Parental somatic and germ-line mosaicism for a multiexon deletion with unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring.

Authors:  D M Milewicz; A M Witz; A C Smith; D K Manchester; G Waldstein; P H Byers
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.